Fulcrum Therapeutics Inc (FULC)
3.02 -0.09 (-2.89%) 14:31 ET [NASDAQ]
3.01 x 2 3.02 x 4
Realtime by (Cboe BZX)
3.01 x 2 3.02 x 4
Realtime - - (-) -
for Wed, Mar 26th, 2025
Results
download Want to compare other data? Select Fields| Symbol | FULC | KOD | IPHA | ||
| Company | Fulcrum Therapeutics Inc | Kodiak Sciences Inc | Innate Pharma S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.17 | 3.21 | 2.0237 | ||
| High | 3.17 | 3.27 | 2.0299 | ||
| Low | 3.00 | 2.99 | 1.8200 | ||
| Last | 3.02 | 3.01 | 1.9100 | ||
| Change | -0.10 | -0.19 | -0.0600 | ||
| % Change | -3.05% | -5.94% | -3.05% | ||
| Volume | 65,860 | 184,018 | 13,822 | ||
| 20-Day Average Volume | 483,416 | 326,891 | 20,413 | ||
| Previous Close | 3.11 | 3.21 | 1.9700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.13 | 3.58 | 2.0258 | ||
| 20-Day Raw Stochastic | 29.76% | 1.91% | 0.00% | ||
| 20-Day Relative Strength | 40.42% | 33.21% | 43.45% | ||
| Weighted Alpha | -36.77 | -52.88 | -55.56 | ||
| Today's Opinion | 100% Sell | 56% Sell | 48% Sell | ||
| Previous Opinion | 100% Sell | 56% Sell | 8% Buy | ||
| Last Month's Opinion | 88% Sell | 24% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.02% since 03/19/25 | -10.00% since 03/19/25 | -9.38% since 03/19/25 | ||
| Low | 2.95 on 03/20/25 | 2.99 on 03/26/25 | 1.8300 on 03/26/25 | ||
| High | 3.34 on 03/25/25 | 3.59 on 03/24/25 | 2.0500 on 03/21/25 | ||
| 1-Month | |||||
| %Chg | -8.73% since 02/26/25 | -27.17% since 02/26/25 | -19.03% since 02/26/25 | ||
| Low | 2.78 on 03/13/25 | 2.99 on 03/26/25 | 1.8300 on 03/26/25 | ||
| High | 3.62 on 03/03/25 | 4.30 on 03/03/25 | 2.3800 on 02/27/25 | ||
| 3-Month | |||||
| %Chg | -37.40% since 12/26/24 | -72.34% since 12/26/24 | -13.27% since 12/26/24 | ||
| Low | 2.78 on 03/13/25 | 2.99 on 03/26/25 | 1.6000 on 01/15/25 | ||
| High | 5.17 on 01/06/25 | 10.90 on 12/27/24 | 2.5900 on 02/24/25 | ||
| 6-Month | |||||
| %Chg | -24.25% since 09/26/24 | +11.25% since 09/26/24 | -14.88% since 09/26/24 | ||
| Low | 2.78 on 03/13/25 | 2.50 on 10/02/24 | 1.2900 on 11/18/24 | ||
| High | 5.17 on 01/06/25 | 11.60 on 12/09/24 | 3.5107 on 12/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 167,875 | 168,660 | 165,145 | ||
| Shares Outstanding, K | 53,979 | 52,624 | 83,830 | ||
| Annual Sales | 80,000,000 | 0 | 66,710,000 | ||
| Annual Net Income | -9,730,000 | -260,490,000 | -8,190,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -21,700,000 | -43,950,000 | N/A | ||
| 60-Month Beta | 2.20 | 2.26 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 02/25/25 | -0.84 on 11/14/24 | N/A | ||
| Latest Earnings Date | 05/12/25 | 03/27/25 | 03/27/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||